English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 45065/58241 (77%)
造訪人次 : 2245104      線上人數 : 252
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋
    請使用永久網址來引用或連結此文件: http://libir.tmu.edu.tw/handle/987654321/58370


    題名: Genetic and Environmental Factors for the Risk of Potentially Malignant Oral Disorders and Prognosis of Oral Squamous Cell Carcinoma
    作者: Thomas Senghore
    貢獻者: 公共衛生學系暨研究所
    葉志清
    關鍵詞: Methylenetetrahydrofolate reductase;potentially malignant oral disorders;oxidative stress;drug-metabolizing gene;DNA repair gene;environmental factors;oral squamous cell carcinoma;concurrent chemoradiotherapy;prognosis;genetic variant
    日期: 2019-07-04
    上傳時間: 2020-01-07 12:44:46 (UTC+8)
    摘要: Introduction
    Oral cancer (OC) poses a serious public health burden, with high morbidity and mortality globally. Over 90% of OC are oral squamous cell carcinoma (OSCC). Potentially malignant oral disorders (PMODs) are highly transformative, contributing to the OC incidence. The pathology of these oral tumors involves multiple and complex biological processes, mediated by both endogenous and exogenous factors that include reactive oxygen species (ROS), genetic and lifestyle factors such as alcohol drinking betel nut chewing and cigarette smoking. The diagnosis and treatment of OSCC have improved over the past decades, however, this has not brought about a remarkable reduction in the mortality. This phenomenon may partly be attributed to the fact that many OSCC cases are diagnosed at an advanced stage, decreasing their likelihood of survival. Evidence has also shown that single nucleotide polymorphisms (SNPs) in DNA repair genes may play a major role in the sensitivity of cancer cells to radiochemotherapy. Thus, we investigate the association between inherent and lifestyle factors on PMODs risks and prognosis of OSCC.
    Methods
    The study uses a multidisciplinary approach combining two study designs. The case-control studies used 709 male subjects (224 cases: 485 controls) to study the association between polymorphisms in MTHFR gene and oxidative stress biomarkers on the risk of PMOD development. The retrospective cohort studies examined the association between polymorphisms in DNA repair genes and prognosis of oral OSCC in 319 male patients receiving concurrent chemotherapy (CCRT). MTHFR C677T and A1298C polymorphisms were determined using polymerase chain reaction and restriction fragment length polymorphism whereas the Sequenom iPLEX MassARRAY system was used for genotyping variants in the DNA repair genes. The measurements of plasma 8-hydroxy-2’-deoxyguanosine (8-OHdG) and 8-isoprostane (8-ISO) were obtained by enzyme-linked immunosorbent assay. Multivariate logistic regression models were used to assess risk factors for PMODs. The Kaplan–Meier curves and multivariate Cox proportional hazard regression models were used to identify factors associated with survival.
    Results
    The results indicate the T-allele in MTHFR C677T polymorphism may be associated with reduced risk for PMODs (odds ratio [OR] = 0.62, 95% confidence interval [CI] = 0.44-0.86), and the 677T/1298A TA haplotype was associated with a decreased risk of PMODs (OR = 0.56, 95% CI = 0.40-0.80). Increased plasma 8-isoprostane (8-ISO) levels are associated with increased risk for PMODs (OR = 1.71, 95% CI = 1.12–2.63; p = 0.013). This positive association was stronger among patients with PMOD subtype of leukoplakia (OR = 1.94, 95% Cl = 1.24–3.06; p = 0.004). The DNA repair SNPs XPC rs2228000 TT genotype (hazard ratio [HR] = 1.81, 95% CI = 0.99–3.29), MLH1 rs1800734 GG genotype (HR = 0.52, 95% CI = 0.27–1.01; p=0.054), XRCC1 rs1799782 CT+TT genotypes (HR = 0.65, 95% CI = 0.43–0.99; p = 0.044) and APEX1 rs1760944 GG genotype (HR = 1.64, 95% CI = 1.00–2.70; p = 0.050) were associated with overall survival. In addition, the genetic variants ERCC5 rs17655 CC genotypes (HR = 1.54, 95% CI = 1.03–2.29), ERCC1 rs735482 CC genotypes (HR = 1.65, 95% CI = 1.06–2.58), MSH2 rs3732183 GG genotype (HR = 0.45; 95% CI = 0.22–0.96; p=0.039), MLH1 rs1800734 GG genotype (HR = 0.49, 95% CI = 0.26–0.92; p=0.028), MUTYH rs3219489 GG genotype (HR = 2.01, 95% CI = 1.31–3.10; p = 0.002), and XRCC2 rs2040639 AA genotype (HR = 0.55, 95% CI=0.31–0.98; p=0.042) were associated with disease-free survival in OSCC patients receiving CCRT.
    Conclusions
    Our findings indicate that the MTHFR C677T T-allele and increased plasma 8-ISO level are important factors in PMOD development. In addition, DNA repair variants XPC rs2228000, ERCC5 rs17655, ERCC1 rs735482, MSH2 rs3732183, MLH1 rs1800734, XRCC1 rs1799782, APEX1 rs1760944, MUTYH rs3219489 and XRCC2 rs2040639 affect survival of patients with advanced OSCC. These SNPs may serve as prognostic markers for OSCC prognosis. These findings may require confirmation in studies of larger samples or other ethnic populations.
    描述: 博士
    指導教授:葉志清
    委員:劉宗榮
    委員:黃祥富
    委員:王紋璋
    委員:吳美滿
    資料類型: thesis
    顯示於類別:[公共衛生學系暨研究所] 博碩士論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    index.html0KbHTML190檢視/開啟


    在TMUIR中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    著作權聲明 Copyright Notice
    • 本平台之數位內容為臺北醫學大學所收錄之機構典藏,包含體系內各式學術著作及學術產出。秉持開放取用的精神,提供使用者進行資料檢索、下載與取用,惟仍請適度、合理地於合法範圍內使用本平台之內容,以尊重著作權人之權益。商業上之利用,請先取得著作權人之授權。

      The digital content on this platform is part of the Taipei Medical University Institutional Repository, featuring various academic works and outputs from the institution. It offers free access to academic research and public education for non-commercial use. Please use the content appropriately and within legal boundaries to respect copyright owners' rights. For commercial use, please obtain prior authorization from the copyright owner.

    • 瀏覽或使用本平台,視同使用者已完全接受並瞭解聲明中所有規範、中華民國相關法規、一切國際網路規定及使用慣例,並不得為任何不法目的使用TMUIR。

      By utilising the platform, users are deemed to have fully accepted and understood all the regulations set out in the statement, relevant laws of the Republic of China, all international internet regulations, and usage conventions. Furthermore, users must not use TMUIR for any illegal purposes.

    • 本平台盡力防止侵害著作權人之權益。若發現本平台之數位內容有侵害著作權人權益情事者,煩請權利人通知本平台維護人員([email protected]),將立即採取移除該數位著作等補救措施。

      TMUIR is made to protect the interests of copyright owners. If you believe that any material on the website infringes copyright, please contact our staff([email protected]). We will remove the work from the repository.

    Back to Top
    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋